Clinical Trial Update: A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating the safety and efficacy of FG-2216 in renal anemia patients not requiring dialysis and not receiving recombinant human eryth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Anemia

Drugs mentioned

• FG-2216

Snippet

Sponsor: Kyntra Bio | Conditions: Renal Anemia | Phase 2 | Status: COMPLETED